Jia, Caiyun
Zhao, Na
Song, Haojing
Hu, Yiting
Xu, Yufang
Guo, Caihui
Bai, Wanjun
Dong, Zhanjun https://orcid.org/0009-0002-3325-3437
Article History
Accepted: 23 September 2024
First Online: 29 October 2024
Declarations
:
: The study was suppported by Shijiazhuang No. 4 Pharmaceutical Co.,Ltd.
: The authors declare that there is no conflict of interest.
: The datasets used or analyzed are available from Zhanjun Dong upon reasonable request.
: This study protocol was approved by the Ethics Committee of Hebei Provincial People's Hospital (approval number: HBRM-H-067, 2021-24-01) and registered in the Chinese Clinical Trial Register (ChiCTR) with registration number CTR20213116 ( #CTR20213116).
: Conception and study designing: WJB and ZJD. Data acquisition: CYJ. Analysis and interpretation: NZ, HJS, YTH, and YFX. Drafting of the manuscript: CYJ and CHG.
: Informed consent forms have been obtained from all subjects.